Quality control technician inspecting medication packaging in a pharmaceutical lab

Services

Named Patient Program

Support for licensed buyers in international markets to access unapproved or orphan drugs via compliant Named Patient Programs.

Pharmex supports licensed buyers and healthcare providers in international markets who need access to unapproved or orphan medicines for individual patients through compliant Named Patient Programs.

We coordinate sourcing, regulatory documentation, and validated delivery so treating physicians can obtain required therapies lawfully and on time.

What's included

  • Orphan and unapproved medicine sourcing
  • Import permit and documentation support
  • Physician-initiated request handling
  • Batch-level traceability and COAs
  • Cold-chain shipping where required
  • Case-by-case regulatory guidance

Who it's for

  • Treating physicians and hospitals abroad
  • International importers and distributors
  • Government and institutional buyers
  • Patient-access programs

Compliance & documentation

Each request is reviewed against local import regulations and export protocols. Supply proceeds only where a compliant, documented pathway exists.

See our compliance framework

Related Services

You may also need

FDA-Approved Medications

Reliable sourcing and supply of FDA-approved drugs across multiple therapeutic categories for pharmacies and healthcare providers.

Learn more

Controlled Substances

Licensed distribution of Schedules II–V drugs, following strict DEA compliance and secure handling protocols.

Learn more

Specialty & Cold Chain

Distribution of temperature-sensitive biologics and specialty pharmaceuticals using validated cold chain logistics.

Learn more

Ready to partner with a licensed global distributor?

Talk to our team about sourcing, licensing verification, and getting your account activated.